Osteonic KRX:226400KOSDAQ
오스테오닉 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days2
Articles tracked3since Sep 11
In Q2 2026, Osteonic reported revenue of ₩13.2bn, up 20.1% year on year, and operating profit of ₩2.4bn. Osteonic (오스테오닉) appeared in 0 Korean news articles and 2 DART filings over the past seven days.
Osteonic quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩13.2bn | +20.1% | ₩2.4bn margin 18.4% | ₩1.8bn |
| Q1 2026 | ₩12.9bn | +35.4% | ₩2.3bn margin 18.1% | ₩2.7bn |
| Q4 2025 derived | ₩13.0bn | +33.7% | ₩2.4bn margin 18.4% | ₩3.7bn |
| Q3 2025 | ₩11.9bn | +45.5% | ₩2.2bn margin 18.7% | ₩2.0bn |
| Q2 2025 | ₩11.0bn | +27.0% | ₩2.7bn margin 25.0% | ₩1.0bn |
| Q1 2025 | ₩9.5bn | +23.8% | ₩1.5bn margin 15.7% | ₩762m |
| Q4 2024 derived | ₩9.7bn | +21.0% | ₩2.3bn margin 23.9% | ₩2.7bn |
| Q3 2024 | ₩8.2bn | +21.0% | ₩1.6bn margin 20.1% | ₩1.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Osteonic top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.